Although cellular therapies represent a promising strategy for a number of conditions, current approaches face major translational hurdles, including limited cell sources and the need for cumbersome pre-processing steps (for example, isolation, induced pluripotency)1,2,3,4,5,6. In vivo cell reprogramming has the potential to enable more-effective cell-based therapies by using readily available cell sources (for example, fibroblasts) and circumventing the need for ex vivo pre-processing7,8. Existing reprogramming methodologies, however, are fraught with caveats, including a heavy reliance on viral transfection9,10. Moreover, capsid size constraints and/or the stochastic nature of status quo approaches (viral and non-viral) pose additional limitations, thus highlighting the need for safer and more deterministic in vivo reprogramming methods11,12. Here, we report a novel yet simple-to-implement non-viral approach to topically reprogram tissues through a nanochannelled device validated with well-established and newly developed reprogramming models of induced neurons and endothelium, respectively. We demonstrate the simplicity and utility of this approach by rescuing necrotizing tissues and whole limbs using two murine models of injury-induced ischaemia.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
npj Regenerative Medicine Open Access 20 October 2022
Cell & Bioscience Open Access 22 July 2021
Scientific Reports Open Access 19 November 2020
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Rosova, I., Dao, M., Capoccia, B., Link, D. & Nolta, J. A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26, 2173–2182 (2008).
Kinoshita, M. et al. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. Atherosclerosis 224, 440–445 (2012).
Losordo, D. W. & Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: cell-based therapies. Circulation 109, 2692–2697 (2004).
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L . & Wu, J. C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat. Med. 19, 998–1004 (2013).
Cunningham, J. J., Ulbright, T. M., Pera, M. F. & Looijenga, L. H. Lessons from human teratomas to guide development of safe stem cell therapies. Nat. Biotechnol. 30, 849–857 (2012).
Leduc, P. R. et al. Towards an in vivo biologically inspired nanofactory. Nat. Nanotech. 2, 3–7 (2007).
Heinrich, C. & Spagnoli, F. M. & Berninger, B. In vivo reprogramming for tissue repair. Nat. Cell Biol. 17, 204–211 (2015).
Karagiannis, P. & Yamanaka, S. The fate of cell reprogramming. Nat. Methods 11, 1006–1008 (2014).
Grande, A. et al. Environmental impact on direct neuronal reprogramming in vivo in the adult brain. Nat. Commun. 4, 2373 (2013).
Morita, R. et al. ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proc. Natl Acad. Sci. USA 112, 160–165 (2015).
Gallego-Perez, D. et al. Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers. Nanomedicine 12, 399–409 (2016).
Marx, V. Cell biology: delivering tough cargo into cells. Nat. Methods 13, 37–40 (2016).
Boukany, P. E. et al. Nanochannel electroporation delivers precise amounts of biomolecules into living cells. Nat. Nanotech. 6, 747–754 (2011).
Sen, C. K. & Ghatak, S. miRNA control of tissue repair and regeneration. Am. J. Pathol. 185, 2629–2640 (2015).
Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035–1041 (2010).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Davis, D. M. & Sowinski, S. Membrane nanotubes: dynamic long-distance connections between animal cells. Nat. Rev. Mol. Cell Biol. 9, 431–436 (2008).
Khanna, S. et al. Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J. Cereb. Blood Flow Metab. 33, 1197–1206 (2013).
Venugopal, V. & Sundaresan, V. B. Polypyrrole-based amperometric cation sensor with tunable sensitivity. J. Intel. Mat. Syst. Str. 27, 1702–1709 (2016).
Venugopal, V., Venkatesh, V., Northcutt, R. G., Maddox, J. & Sundaresan, V. B. Nanoscale polypyrrole sensors for near-field electrochemical measurements. Sensors Actuat. B Chem. 242, 1193–1200 (2017).
Hunt, D. P. et al. A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin. Stem Cells 26, 163–172 (2008).
Higgins, C. A . et al. Reprogramming of human hair follicle dermal papilla cells into induced pluripotent stem cells. J. Invest. Dermatol. 132, 1725–1727 (2012).
Helisch, A. et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler. Thromb. Vasc. Biol. 26, 520–526 (2006).
Chalothorn, D., Clayton, J. A., Zhang, H., Pomp, D. & Faber, J. E. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol. Genomics 30, 179–191 (2007).
Anokye-Danso, F. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376–388 (2011).
Limbourg, A. et al. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat. Protoc. 4, 1737–1746 (2009).
Fiedler, G. B. et al. Localized semi-LASER dynamic 31P magnetic resonance spectroscopy of the soleus during and following exercise at 7 T. MAGMA 28, 493–501 (2015).
Gnyawali, S. C. et al. High-frequency high-resolution echocardiography: first evidence on non-invasive repeated measure of myocardial strain, contractility, and mitral regurgitation in the ischemia-reperfused murine heart. J. Vis. Exp. 2010, e1781 (2010).
Roy, S . et al. Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc. Natl Acad. Sci. USA 104, 14472–14477 (2007).
Rink, C. et al. Oxygen-sensitive outcomes and gene expression in acute ischemic stroke. J. Cereb. Blood Flow Metab. 30, 1275–1287 (2010).
Roy, S., Khanna, S., Rink, C., Biswas, S. & Sen, C. K. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol. Genomics 34, 162–184 (2008).
Funding for C.K.S. was partly provided by NIGMS/NINR (R01GM07718507, R01GM10801402, R01NR01567601, R01NR01389804 and R01NS42617) and a philanthropic gift from Leslie and Abigail Wexner. Funding for L.J.L. was partly provided by NIBIB (R21EB017539), NSF (NSEC EEC-0914790) and the National Center for the Advancing Translational Sciences (UL1TR001070). Funding for D.G.-P., S.K. and C.R. was partly provided by NINDS (R21NS099869). Additional funding for D.G.-P. and S.K. was provided in part by the NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org), grant DK076169 (U24DK076169). J.J.O., V.B.S., S.K., C.R. and S.R. acknowledge financial support from NIH (R01HL132355, R21EB017539, R01NS099869 and R01DK076566) and NSF (1325114), respectively. The authors thank T. Wilgus and B. Wulff (Department of Pathology, The Ohio State University) for providing the Col1A1 mice used in this study. Fsp1-Cre mice were a gift from A. Deb (University of California, Los Angeles). Etv2 and Fli1 plasmids were donated by A. Ferdous (Department of Internal Medicine, UT Southwestern). Foxc2 plasmid was donated by T. Kume (Department of Medicine-Cardiology and Pharmacology, Northwestern University-FCVRI, Chicago). X. Wang (The Ohio State University) provided support with plasmid design and preparation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Sciences, National Science Foundation or the National Institutes of Health. This work was sponsored by and represents activity of The Ohio State University Center for Regenerative Medicine and Cell Based Therapies (regenerativemedicine.osu.edu) and Nanoscale Engineering Center for Affordable Nanoengineering of Polymeric Biomedical Devices.
The authors declare no competing financial interests.
About this article
Cite this article
Gallego-Perez, D., Pal, D., Ghatak, S. et al. Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue. Nature Nanotech 12, 974–979 (2017). https://doi.org/10.1038/nnano.2017.134
This article is cited by
npj Regenerative Medicine (2022)
Nano Research (2022)
Cell & Bioscience (2021)
Fabrication and use of silicon hollow-needle arrays to achieve tissue nanotransfection in mouse tissue in vivo
Nature Protocols (2021)